FANCD2 overexpression increases the risk of metastasis in esophageal squamous cell carcinoma (ESCC) by activating DNA replication and regulating cell cycle progression, which is associated with the negative prognosis of ESCC (Lei et al., 2020). Here, FANCD2 is linked to esophageal squamous cell carcinoma.